Nexalin Technology Announces Publication Of Groundbreaking Deep-Brain Stimulation Study In Leading Peer-Reviewed Journal; Validates The Ability Of Nexalin's Neurostimulation Device To Penetrate Deep Brain Structures
Portfolio Pulse from Benzinga Newsdesk
Nexalin Technology, Inc. (NASDAQ:NXL) announced the publication of a research article in Nature's Molecular Psychiatry, validating the ability of Nexalin's neurostimulation device to penetrate deep brain structures. The study revealed that Nexalin's non-invasive, deep frequency stimulation medical device can directly stimulate areas of the brain associated with trauma and mental health disease. The CEO of Nexalin Technology, Mark White, stated that the research results have significant scientific value and demonstrate Nexalin's leadership in the field of non-invasive neural stimulation.
October 16, 2023 | 12:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The publication of Nexalin's research in a leading peer-reviewed journal validates the effectiveness of its neurostimulation device, potentially leading to increased demand and positive impact on the company's stock.
The publication of Nexalin's research in a leading peer-reviewed journal provides strong validation for the effectiveness of its neurostimulation device. This could lead to increased demand for the product, potentially driving up the company's revenues and positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100